reference/14720453

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14720453

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	66
issn	0168-3659
issueIdentifier	1
pageRange	60-66
publicationName	Journal of controlled release : official journal of the Controlled Release Society
startingPage	60
bibliographicCitation	Shim G, Han SE, Yu YH, Lee S, Lee HY, Kim K, Kwon IC, Park TG, Kim YB, Choi YS, Kim CW, Oh YK. Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug. J Control Release. 2011 Oct 10;155(1):60–6. doi: 10.1016/j.jconrel.2010.10.017. PMID: 20971142.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3df1e162d1e65c08d7bdf9bbb6921a83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8e9a7df8730b1120c8717839659f749 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad34949fbab201b300280c922d891464 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f181556adeea77cbc9460cf9f18d9f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72f59737eaa81dff17b3d2f55df1508f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d50f9252e30c7e348e70e80579a1a25 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a150189aca69b7619e641845670e63d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e2210b76aa3fa3c4023c8b2a377cf0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6edf99084f5c885b0fbea3a1cc6e4de9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cfae6865ac398bfd89b73aec5740ada http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_711531eda053dd9ef5d1ec2e214bcd47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f85dc9e5115838a622b30df182fb6bb4
date	2011-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/20971142 https://doi.org/10.1016/j.jconrel.2010.10.017
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21032 https://portal.issn.org/resource/ISSN/0168-3659
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug
discusses	http://id.nlm.nih.gov/mesh/M0474910 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0010739 http://id.nlm.nih.gov/mesh/M0406100 http://id.nlm.nih.gov/mesh/M0028673 http://id.nlm.nih.gov/mesh/M0015250 http://id.nlm.nih.gov/mesh/M0012600 http://id.nlm.nih.gov/mesh/M0288128 http://id.nlm.nih.gov/mesh/M0003681 http://id.nlm.nih.gov/mesh/M0215606 http://id.nlm.nih.gov/mesh/M0093787
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009829Q000737 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D008081Q000737 http://id.nlm.nih.gov/mesh/D002412Q000737 http://id.nlm.nih.gov/mesh/D034741Q000008 http://id.nlm.nih.gov/mesh/D006877Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D034741Q000235 http://id.nlm.nih.gov/mesh/D009369Q000235 http://id.nlm.nih.gov/mesh/D006877Q000627 http://id.nlm.nih.gov/mesh/D000077337 http://id.nlm.nih.gov/mesh/D020868 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D034741Q000627 http://id.nlm.nih.gov/mesh/D002460 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D064549 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D019253Q000235 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D009369Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e75b04b99ad7f9547bbdf30bf933fe9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129552408 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127819107 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129625394 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368393

Total number of triples: 72.